Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 591

1.

Chronological changes of skin eruptions in an infantile case of annular pustular psoriasis.

Hata A, Egawa G, Nomura T, Kabashima K.

J Dermatol. 2019 May 20. doi: 10.1111/1346-8138.14929. [Epub ahead of print] No abstract available.

PMID:
31106884
2.

Development of an LC-MS/MS-based method for quantitation of osimertinib in human plasma and cerebrospinal fluid.

Irie K, Nanjo S, Hata A, Yamasaki Y, Okada Y, Katakami N, Fukushima S.

Bioanalysis. 2019 May 14. doi: 10.4155/bio-2018-0292. [Epub ahead of print]

PMID:
31084202
3.

Myelodysplastic Syndrome-Associated SRSF2 Mutations Cause Splicing Changes by Altering Binding Motif Sequences.

Masaki S, Ikeda S, Hata A, Shiozawa Y, Kon A, Ogawa S, Suzuki K, Hakuno F, Takahashi SI, Kataoka N.

Front Genet. 2019 Apr 16;10:338. doi: 10.3389/fgene.2019.00338. eCollection 2019.

4.

Molecular cytogenetic characterization of repetitive sequences comprising centromeric heterochromatin in three Anseriformes species.

Uno Y, Nishida C, Hata A, Ishishita S, Matsuda Y.

PLoS One. 2019 Mar 26;14(3):e0214028. doi: 10.1371/journal.pone.0214028. eCollection 2019.

5.

Inequality within a community at the neighborhood level and the incidence of mood disorders in Japan: a multilevel analysis.

Fujita M, Nagashima K, Takahashi S, Hata A.

Soc Psychiatry Psychiatr Epidemiol. 2019 Mar 22. doi: 10.1007/s00127-019-01687-w. [Epub ahead of print]

PMID:
30903241
6.

Deregulation of Drosha in the pathogenesis of hereditary hemorrhagic telangiectasia.

Hata A, Lagna G.

Curr Opin Hematol. 2019 May;26(3):161-169. doi: 10.1097/MOH.0000000000000493.

7.

Investigation of novel variations of ORAI1 gene and their association with Kawasaki disease.

Thiha K, Mashimo Y, Suzuki H, Hamada H, Hata A, Hara T, Tanaka T, Ito K, Onouchi Y; Japan Kawasaki Disease Genome Consortium.

J Hum Genet. 2019 Jun;64(6):511-519. doi: 10.1038/s10038-019-0588-2. Epub 2019 Mar 11.

PMID:
30853710
8.

Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial.

Hamada H, Suzuki H, Onouchi Y, Ebata R, Terai M, Fuse S, Okajima Y, Kurotobi S, Hirai K, Soga T, Ishiguchi Y, Okuma Y, Takada N, Yanai M, Sato J, Nakayashiro M, Ayusawa M, Yamamoto E, Nomura Y, Hashimura Y, Ouchi K, Masuda H, Takatsuki S, Hirono K, Ariga T, Higaki T, Otsuki A, Terauchi M, Aoyagi R, Sato T, Fujii Y, Fujiwara T, Hanaoka H, Hata A; KAICA trial Investigators.

Lancet. 2019 Mar 16;393(10176):1128-1137. doi: 10.1016/S0140-6736(18)32003-8. Epub 2019 Mar 7. Erratum in: Lancet. 2019 Mar 30;393(10178):1298. Lancet. 2019 Apr 13;393(10180):1504.

PMID:
30853151
9.

Association between blood manganese level during pregnancy and birth size: The Japan environment and children's study (JECS).

Yamamoto M, Sakurai K, Eguchi A, Yamazaki S, Nakayama SF, Isobe T, Takeuchi A, Sato T, Hata A, Mori C, Nitta H; Japan Environment and Children's Study Group:.

Environ Res. 2019 May;172:117-126. doi: 10.1016/j.envres.2019.02.007. Epub 2019 Feb 8.

10.

Precise Anatomical Sublobar Resection Using a 3D Medical Image Analyzer and Fluorescence-Guided Surgery With Transbronchial Instillation of Indocyanine Green.

Sekine Y, Itoh T, Toyoda T, Kaiho T, Koh E, Kamata T, Hoshino H, Hata A.

Semin Thorac Cardiovasc Surg. 2019 Jan 5. pii: S1043-0679(18)30413-1. doi: 10.1053/j.semtcvs.2019.01.004. [Epub ahead of print]

PMID:
30616007
11.
12.

Volumetric analysis of the thymic epithelial tumors: correlation of tumor volume with the WHO classification and Masaoka staging.

Sato Y, Yanagawa M, Hata A, Enchi Y, Kikuchi N, Honda O, Nakanishi K, Tomiyama N.

J Thorac Dis. 2018 Oct;10(10):5822-5832. doi: 10.21037/jtd.2018.09.133.

13.

Soy product and isoflavone intake associations with allergic diseases in Japanese workers: rhinitis, dermatitis and asthma.

Nakamoto M, Shuto E, Nakamoto A, Hata A, Aki N, Shikama Y, Bando Y, Ichihara T, Minagawa T, Tamura A, Kuwamura Y, Funaki M, Sakai T.

Asia Pac J Clin Nutr. 2018;27(6):1277-1285. doi: 10.6133/apjcn.201811_27(6).0015.

14.

Does afatinib plus bevacizumab combination therapy induce positive conversion of T790M in previously-negative patients?

Hata A, Katakami N, Kaji R, Yokoyama T, Kaneda T, Tamiya M, Inoue T, Kimura H, Yano Y, Tamura D, Morita S, Negoro S; HANSHIN Oncology Group.

Oncotarget. 2018 Oct 5;9(78):34765-34771. doi: 10.18632/oncotarget.26192. eCollection 2018 Oct 5.

15.

KRAS G12C NSCLC Models Are Sensitive to Direct Targeting of KRAS in Combination with PI3K Inhibition.

Misale S, Fatherree JP, Cortez E, Li C, Bilton S, Timonina D, Myers DT, Lee D, Gomez-Caraballo M, Greenberg M, Nangia V, Greninger P, Egan RK, McClanaghan J, Stein GT, Murchie E, Zarrinkar PP, Janes MR, Li LS, Liu Y, Hata AN, Benes CH.

Clin Cancer Res. 2019 Jan 15;25(2):796-807. doi: 10.1158/1078-0432.CCR-18-0368. Epub 2018 Oct 16.

PMID:
30327306
16.

Chronological changes in epidemiological characteristics of lower urinary tract urolithiasis in Japan.

Sakamoto S, Miyazawa K, Yasui T, Iguchi T, Fujita M, Nishimatsu H, Masaki T, Hasegawa T, Hibi H, Arakawa T, Ando R, Kato Y, Ishito N, Yamaguchi S, Takazawa R, Tsujihata M, Taguchi M, Akakura K, Hata A, Ichikawa T.

Int J Urol. 2019 Jan;26(1):96-101. doi: 10.1111/iju.13817. Epub 2018 Oct 11.

PMID:
30308705
17.

Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316).

Tachihara M, Negoro S, Inoue T, Tamiya M, Akazawa Y, Uenami T, Urata Y, Hattori Y, Hata A, Katakami N, Yokota S.

BMC Cancer. 2018 Oct 3;18(1):946. doi: 10.1186/s12885-018-4819-2.

18.

Bone morphogenetic protein signaling is required for RAD51-mediated maintenance of genome integrity in vascular endothelial cells.

Vattulainen-Collanus S, Southwood M, Yang XD, Moore S, Ghatpande P, Morrell NW, Lagna G, Hata A.

Commun Biol. 2018 Sep 24;1:149. doi: 10.1038/s42003-018-0152-1. eCollection 2018.

19.

Differences in apoptotic signaling and toxicity between dimethylmonothioarsinic acid (DMMTAV) and its active metabolite, dimethylarsinous acid (DMAIII), in HepaRG cells: Possibility of apoptosis cascade based on diversity of active metabolites of DMMTAV.

Shimoda Y, Kato K, Asami S, Kurita M, Kurosawa H, Toriyama M, Miura M, Hata A, Endo Y, Endo G, An Y, Yamanaka K.

J Trace Elem Med Biol. 2018 Dec;50:188-197. doi: 10.1016/j.jtemb.2018.07.003. Epub 2018 Jul 10.

PMID:
30262279
20.

Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion.

Piotrowska Z, Isozaki H, Lennerz JK, Gainor JF, Lennes IT, Zhu VW, Marcoux N, Banwait MK, Digumarthy SR, Su W, Yoda S, Riley AK, Nangia V, Lin JJ, Nagy RJ, Lanman RB, Dias-Santagata D, Mino-Kenudson M, Iafrate AJ, Heist RS, Shaw AT, Evans EK, Clifford C, Ou SI, Wolf B, Hata AN, Sequist LV.

Cancer Discov. 2018 Dec;8(12):1529-1539. doi: 10.1158/2159-8290.CD-18-1022. Epub 2018 Sep 26.

PMID:
30257958

Supplemental Content

Loading ...
Support Center